Mettler-Toledo International (MTD) Projected to Post Earnings on Thursday

Mettler-Toledo International (NYSE:MTD) is expected to post its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Mettler-Toledo International to post earnings of $12.76 per share and revenue of $1.1047 billion for the quarter. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 6, 2026 at 8:30 AM ET.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $997.36 million. During the same quarter last year, the firm posted $10.21 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, analysts expect Mettler-Toledo International to post $43 EPS for the current fiscal year and $48 EPS for the next fiscal year.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,400.86 on Thursday. The firm’s 50-day moving average price is $1,434.10 and its 200-day moving average price is $1,350.38. The company has a market capitalization of $28.62 billion, a PE ratio of 34.93, a P/E/G ratio of 4.24 and a beta of 1.41. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,525.17.

Insiders Place Their Bets

In related news, Director Elisha W. Finney sold 474 shares of Mettler-Toledo International stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total value of $679,512.18. Following the completion of the sale, the director directly owned 311 shares in the company, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 236 shares of the business’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the transaction, the insider directly owned 159 shares of the company’s stock, valued at approximately $225,554.22. This trade represents a 59.75% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 19,565 shares of company stock worth $28,683,737. 0.77% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. PharVision Advisers LLC purchased a new stake in shares of Mettler-Toledo International during the 3rd quarter valued at about $248,000. Polymer Capital Management US LLC purchased a new stake in Mettler-Toledo International during the third quarter valued at approximately $277,000. Modern Wealth Management LLC raised its position in Mettler-Toledo International by 6.5% in the second quarter. Modern Wealth Management LLC now owns 293 shares of the medical instruments supplier’s stock worth $344,000 after acquiring an additional 18 shares during the period. EP Wealth Advisors LLC bought a new position in Mettler-Toledo International in the second quarter worth approximately $282,000. Finally, Benjamin Edwards Inc. boosted its stake in shares of Mettler-Toledo International by 4.8% during the 2nd quarter. Benjamin Edwards Inc. now owns 218 shares of the medical instruments supplier’s stock worth $256,000 after acquiring an additional 10 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on MTD shares. The Goldman Sachs Group began coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Evercore ISI upped their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a research note on Monday, December 15th. Wells Fargo & Company boosted their target price on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Finally, Barclays reduced their price target on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $1,441.67.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.